Literature DB >> 24334265

A novel microscopy-based high-throughput screening method to identify proteins that regulate global histone modification levels.

Roy Baas1, Daphne Lelieveld, Hetty van Teeffelen, Philip Lijnzaad, Bas Castelijns, F M van Schaik, Michiel Vermeulen, David A Egan, H Th Marc Timmers, Petra de Graaf.   

Abstract

Posttranslational modifications of histones play an important role in the regulation of gene expression and chromatin structure in eukaryotes. The balance between chromatin factors depositing (writers) and removing (erasers) histone marks regulates the steady-state levels of chromatin modifications. Here we describe a novel microscopy-based screening method to identify proteins that regulate histone modification levels in a high-throughput fashion. We named our method CROSS, for Chromatin Regulation Ontology SiRNA Screening. CROSS is based on an siRNA library targeting the expression of 529 proteins involved in chromatin regulation. As a proof of principle, we used CROSS to identify chromatin factors involved in histone H3 methylation on either lysine-4 or lysine-27. Furthermore, we show that CROSS can be used to identify chromatin factors that affect growth in cancer cell lines. Taken together, CROSS is a powerful method to identify the writers and erasers of novel and known chromatin marks and facilitates the identification of drugs targeting epigenetic modifications.

Entities:  

Keywords:  RNA interference; RNAi; cancer and cancer drugs; cell-based assays; epigenetics; microscopy; shRNA

Mesh:

Substances:

Year:  2013        PMID: 24334265     DOI: 10.1177/1087057113515024

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  3 in total

1.  De Novo Heterozygous POLR2A Variants Cause a Neurodevelopmental Syndrome with Profound Infantile-Onset Hypotonia.

Authors:  Hanneke A Haijes; Maria J E Koster; Holger Rehmann; Dong Li; Hakon Hakonarson; Gerarda Cappuccio; Miroslava Hancarova; Daphne Lehalle; Willie Reardon; G Bradley Schaefer; Anna Lehman; Ingrid M B H van de Laar; Coranne D Tesselaar; Clesson Turner; Alice Goldenberg; Sophie Patrier; Julien Thevenon; Michele Pinelli; Nicola Brunetti-Pierri; Darina Prchalová; Markéta Havlovicová; Markéta Vlckova; Zdeněk Sedláček; Elena Lopez; Vassilis Ragoussis; Alistair T Pagnamenta; Usha Kini; Harmjan R Vos; Robert M van Es; Richard F M A van Schaik; Ton A J van Essen; Maria Kibaek; Jenny C Taylor; Jennifer Sullivan; Vandana Shashi; Slave Petrovski; Christina Fagerberg; Donna M Martin; Koen L I van Gassen; Rolph Pfundt; Marni J Falk; Elizabeth M McCormick; H T Marc Timmers; Peter M van Hasselt
Journal:  Am J Hum Genet       Date:  2019-07-25       Impact factor: 11.025

2.  The mixed lineage leukemia 4 (MLL4) methyltransferase complex is involved in transforming growth factor beta (TGF-β)-activated gene transcription.

Authors:  Roy Baas; Hetty A A M van Teeffelen; Sjoerd J D Tjalsma; H Th Marc Timmers
Journal:  Transcription       Date:  2017-11-03

3.  PHF6 promotes non-homologous end joining and G2 checkpoint recovery.

Authors:  Daniël O Warmerdam; Ignacio Alonso-de Vega; Wouter W Wiegant; Bram van den Broek; Magdalena B Rother; Rob Mf Wolthuis; Raimundo Freire; Haico van Attikum; René H Medema; Veronique Aj Smits
Journal:  EMBO Rep       Date:  2019-11-29       Impact factor: 8.807

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.